Vaxcyte, Inc. (NASDAQ: PCVX) is seeing a significant rise in its shares this morning, climbing 35.85% to $109.71 during the pre-market session. This increase comes
On January 13, Vaxcyte Inc. (PCVX) announced the pricing of a $100 million public offering of its common stock shares. In the previous market session,
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.